State Key Laboratory of Molecular Oncology, Department of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, PR China.
J Pathol. 2020 Jun;251(2):135-146. doi: 10.1002/path.5434. Epub 2020 May 27.
Intestinal-type gastric cancer (IGC) has a clear and multistep histological evolution. No studies have comprehensively explored gastric tumorigenesis from inflammation through low-grade intraepithelial neoplasia (LGIN) and high-grade intraepithelial neoplasia (HGIN) to early gastric cancer (EGC). We sought to investigate the characteristics participating in IGC tumorigenesis and identify related prognostic information within the process. RNA expression profiles of 94 gastroscopic biopsies from 47 patients, including gastric precancerous lesions (GPL: LGIN and HGIN), EGC, and paired controls, were detected by Agilent Microarray. During IGC tumorigenesis from LGIN through HGIN to EGC, the number of activity-changed tumor hallmarks increased. LGIN and HGIN had similar expression profiles when compared to EGC. We observed an increase in the stemness of gastric epithelial cells in LGIN, HGIN, and EGC, and we found 27 consistent genes that might contribute to dedifferentiation, including five driver genes. Remarkably, we perceived that the immune microenvironment was more active in EGC than in GPL, especially in the infiltration of lymphocytes and macrophages. We identified a five-gene signature from the gastric tumorigenesis process that could independently predict the overall survival and disease-free survival of GC patients (log-rank test: p < 0.0001), and the robustness was verified in an independent cohort (n > 300) and by comparing with two established prognostic signatures in GC. In conclusion, during IGC tumorigenesis, cancer-like changes occur in LGIN and accumulate in HGIN and EGC. The immune microenvironment is more active in EGC than in LGIN and HGIN. The identified signature from the tumorigenesis process has robust prognostic significance for GC patients. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.
肠型胃癌(IGC)具有明确的多步骤组织学演变过程。目前尚无研究全面探讨从炎症经低级别上皮内瘤变(LGIN)和高级别上皮内瘤变(HGIN)到早期胃癌(EGC)的胃肿瘤发生过程。我们旨在研究参与 IGC 肿瘤发生的特征,并确定该过程中的相关预后信息。通过 Agilent Microarray 检测了 47 名患者的 94 份胃镜活检标本的 RNA 表达谱,包括胃癌前病变(GPL:LGIN 和 HGIN)、EGC 以及配对对照。在 IGC 从 LGIN 经过 HGIN 发展为 EGC 的过程中,发生改变的肿瘤标志数量增加。与 EGC 相比,LGIN 和 HGIN 具有相似的表达谱。我们观察到 LGIN、HGIN 和 EGC 中胃上皮细胞的干性增加,并且发现了 27 个可能有助于去分化的一致基因,其中包括 5 个驱动基因。值得注意的是,我们发现与 GPL 相比,EGC 中的免疫微环境更为活跃,尤其是淋巴细胞和巨噬细胞的浸润。我们从胃肿瘤发生过程中鉴定出一个可以独立预测 GC 患者总生存期和无病生存期的 5 基因签名(对数秩检验:p<0.0001),并在独立队列(n>300)和通过与 GC 中的两个已建立的预后签名进行比较进行了验证。总之,在 IGC 肿瘤发生过程中,LGIN 中出现类似癌症的变化,并在 HGIN 和 EGC 中累积。与 LGIN 和 HGIN 相比,EGC 中的免疫微环境更为活跃。从肿瘤发生过程中鉴定出的签名对 GC 患者具有稳健的预后意义。
World J Gastroenterol. 2014-12-21
Technol Cancer Res Treat. 2024
Gastroenterol Res Pract. 2019-12-1
J Gastroenterol Hepatol. 2021-11
J Biomed Res. 2024-9-25
Cancer Immunol Immunother. 2025-2-1
Braz J Med Biol Res. 2024
Gastric Cancer. 2024-11
Technol Cancer Res Treat. 2024
Virchows Arch. 2024-4
Front Immunol. 2019-1-29
Clin Cancer Res. 2018-4-17
Immunity. 2018-4-5
Methods Mol Biol. 2018